D.E. van Diermen

792 total citations
26 papers, 520 citations indexed

About

D.E. van Diermen is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, D.E. van Diermen has authored 26 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in D.E. van Diermen's work include Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). D.E. van Diermen is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Lipoproteins and Cardiovascular Health (5 papers). D.E. van Diermen collaborates with scholars based in Netherlands, Canada and United States. D.E. van Diermen's co-authors include I. van der Waal, Johan Hoogstraten, Irene H. A. Aartman, J Kastelein, C Boelen, H. D. Bakker, Björn E. Groenemeijer, A. van den Ende, H.C. Knipscheer and Harry R. Büller and has published in prestigious journals such as Journal of Lipid Research, European Journal of Biochemistry and Thrombosis and Haemostasis.

In The Last Decade

D.E. van Diermen

23 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.E. van Diermen Netherlands 11 218 213 120 104 52 26 520
Jurenne D. Hooi Netherlands 8 112 0.5× 378 1.8× 81 0.7× 61 0.6× 28 0.5× 12 476
Nakarin Sansanayudh Thailand 10 155 0.7× 95 0.4× 72 0.6× 62 0.6× 31 0.6× 32 422
Shahul Valavoor United States 6 136 0.6× 125 0.6× 26 0.2× 34 0.3× 33 0.6× 12 353
Asmir I. Syed United States 16 755 3.5× 348 1.6× 58 0.5× 71 0.7× 12 0.2× 40 900
J Launbjerg Denmark 12 502 2.3× 135 0.6× 98 0.8× 15 0.1× 14 0.3× 33 633
Zbigniew Heleniak Poland 13 110 0.5× 46 0.2× 16 0.1× 56 0.5× 19 0.4× 50 393
Viktor Wintzell Sweden 15 61 0.3× 198 0.9× 23 0.2× 325 3.1× 23 0.4× 24 634
Gabriel Sardi United States 12 325 1.5× 218 1.0× 45 0.4× 49 0.5× 17 0.3× 38 518
J.M. Thorp United Kingdom 9 109 0.5× 111 0.5× 25 0.2× 179 1.7× 23 0.4× 10 539
Fernando Borda Spain 14 155 0.7× 413 1.9× 20 0.2× 13 0.1× 33 0.6× 57 868

Countries citing papers authored by D.E. van Diermen

Since Specialization
Citations

This map shows the geographic impact of D.E. van Diermen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.E. van Diermen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.E. van Diermen more than expected).

Fields of papers citing papers by D.E. van Diermen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.E. van Diermen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.E. van Diermen. The network helps show where D.E. van Diermen may publish in the future.

Co-authorship network of co-authors of D.E. van Diermen

This figure shows the co-authorship network connecting the top 25 collaborators of D.E. van Diermen. A scholar is included among the top collaborators of D.E. van Diermen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.E. van Diermen. D.E. van Diermen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Diermen, D.E. van, et al.. (2024). Postoperative risk of bleeding after removal of third molars in healthy patients – a prospective observational clinical study. Nederlands Tijdschrift voor Tandheelkunde. 131(07/08). 307–315. 2 indexed citations
3.
Diermen, D.E. van, et al.. (2020). Oral adverse effects: drug‐induced tongue disorders. Oral Diseases. 27(6). 1528–1541. 7 indexed citations
4.
Brinkman, David J., D.E. van Diermen, J.J.M. Bruers, et al.. (2019). Are Dutch dental students and dental‐care providers competent prescribers of drugs?. European Journal Of Oral Sciences. 127(6). 531–538. 6 indexed citations
5.
Diermen, D.E. van, et al.. (2017). Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. Thrombosis and Haemostasis. 117(7). 1432–1439. 5 indexed citations
6.
Diermen, D.E. van, I. van der Waal, & Johan Hoogstraten. (2013). Management recommendations for invasive dental treatment in patients using oral antithrombotic medication, including novel oral anticoagulants. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 116(6). 709–716. 68 indexed citations
7.
Napeñas, Joel J., et al.. (2013). Review of postoperative bleeding risk in dental patients on antiplatelet therapy. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 115(4). 491–499. 64 indexed citations
8.
Diermen, D.E. van, et al.. (2012). Survey response of oral and maxillofacial surgeons on invasive procedures in patients using antithrombotic medication. International Journal of Oral and Maxillofacial Surgery. 42(4). 502–507. 15 indexed citations
9.
Diermen, D.E. van, et al.. (2011). Treating dental patients who use oral antithrombotic medication. The Journal of the American Dental Association. 142(12). 1376–1382. 17 indexed citations
10.
Lockhart, Peter B., Catherine Hong, & D.E. van Diermen. (2010). The Influence of Systemic Diseases on the Diagnosis of Oral Diseases: A Problem-Based Approach. Dental Clinics of North America. 55(1). 15–28. 4 indexed citations
11.
Diermen, D.E. van, et al.. (2009). Dental management of patients using antithrombotic drugs: critical appraisal of existing guidelines. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology. 107(5). 616–624. 43 indexed citations
12.
Diermen, D.E. van, J. Hoogstraten, & I. van der Waal. (2008). [Dental procedures for patients using oral anticoagulation: new insights].. PubMed. 115(4). 225–9. 3 indexed citations
13.
Diermen, D.E. van, et al.. (2007). Dental enamel defects in children with coeliac disease. International Journal of Paediatric Dentistry. 17(3). 163–168. 57 indexed citations
14.
Diermen, D.E. van, H.S. Brand, & A Vissink. (2006). [The importance of adequate medical history taking in dentistry].. PubMed. 113(5). 172–5. 1 indexed citations
15.
Diermen, D.E. van, et al.. (2004). [Postoperative course after uncomplicated tooth extractions in adults. Experiences in a university mouth disease and jaw surgery clinic].. PubMed. 111(1). 2–4. 1 indexed citations
16.
Knipscheer, H.C., C Boelen, J Kastelein, et al.. (1996). Short-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia. Pediatric Research. 39(5). 867–871. 124 indexed citations
17.
Diermen, D.E. van, et al.. (1996). Origin and migration of an Afrikaner founder mutation FHAfrikaner-2 (V408M) causing familial hypercholesterolemia.. PubMed. 10(1). 1–10. 8 indexed citations
18.
Defesche, Joep C., D.E. van Diermen, Peter Lansberg, et al.. (1993). South African founder mutations in the low-density lipoprotein receptor gene causing familial hypercholesterolemia in the Dutch population. Human Genetics. 92(6). 567–570. 24 indexed citations
19.
Bruin, Taco, John J.P. Kastelein, D.E. van Diermen, et al.. (1992). A missense mutation Pro157Arg in lipoprotein lipase (LPLNijmegen) resulting in loss of catalytic activity. European Journal of Biochemistry. 208(2). 267–272. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jurenne D. Hooi Breakdown of academic impact, for papers by Nakarin Sansanayudh Breakdown of academic impact, for papers by Shahul Valavoor Breakdown of academic impact, for papers by Asmir I. Syed Breakdown of academic impact, for papers by J Launbjerg Breakdown of academic impact, for papers by Zbigniew Heleniak Breakdown of academic impact, for papers by Viktor Wintzell Breakdown of academic impact, for papers by Gabriel Sardi Breakdown of academic impact, for papers by J.M. Thorp Breakdown of academic impact, for papers by Fernando Borda
Rankless by CCL
2026